课题基金 / 基金详情

Unraveling the 10q AMD Risk Locus

Unraveling the 10q AMD Risk Locus
揭开 10 季度 AMD 风险轨迹
批准号:
9340188
负责人:
EDWIN M STONE
金额:
$49.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2020-08-31

项目摘要

项目成果

EDWIN M STONE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Age-related macular degeneration (AMD) is the most common cause of severe visual loss in the developed world, affecting more than 10 million people in the United States alone. Approximately 1 in 3 people over the age of 75 are affected to some degree. A significant fraction of this disease is genetic, with major genetic risk factors on chromosomes 1 and 10. In this study, we will take advantage of molecular genetics, state of the art computer-assisted image analysis, large patient populations, well characterized donor eye tissue, induced pluripotent stem cells and CRISPR based genome editing to determine the molecular basis of how variations in AMD loci increase risk of AMD. These studies will provide new insight into the pathophysiologic mechanisms of AMD that will be valuable for the development of more specific diagnostic methods and more effective therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unraveling the 10q AMD Risk Locus
  • 批准号:
    9762936
  • 项目类别:
  • 资助金额:
    $49.58万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
CRISPR-Cas9 based treatment of dominant retinal degeneration
  • 批准号:
    10380840
  • 项目类别:
  • 资助金额:
    $37.43万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
CRISPR-Cas9 based treatment of dominant retinal degeneration
  • 批准号:
    9886365
  • 项目类别:
  • 资助金额:
    $39.49万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
CRISPR/Cas9-mediated correction of mutations that cause inherited retinal degenerations
  • 批准号:
    9238770
  • 项目类别:
  • 资助金额:
    $34.31万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
海外基金